Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Mosunetuzumab
(Mosunetuzumab)
[1] Mosunetuzumab[1] Mosunetuzumab (Mosunetuzumab, Mosunetuzumab-axgb) 💬 [2] CD3E,
MS4A1 💬
[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 49 💬